title: A closer look at 3TC. Interview by Mark Mascolini.
authors.affiliation: Glaxo Wellcome Company, Research Triangle Park, NC.
authors.forename: M
authors.initials: M
authors.lastname: Rubin
mesh_terms: D000998:Antiviral Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D018791:CD4 Lymphocyte Count; D004359:Drug Therapy, Combination; D015658:HIV Infections / Q000188:drug therapy*; D006509:Hepatitis B / Q000188:drug therapy; D006801:Humans; D019259:Lamivudine; D016047:Zalcitabine / Q000008:administration & dosage / Q000627:therapeutic use*; D015215:Zidovudine / Q000008:administration & dosage / Q000627:therapeutic use
chemical_list: D000998:Antiviral Agents; D019259:Lamivudine; D015215:Zidovudine; D016047:Zalcitabine